Frontlight ResearchEarly access
Trial site
Hamilton Health Sciences-Juravinski Cancer Centre
- 10running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Multiple myeloma3 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Ovarian cancer2 trials
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- and 3 more
- Phase
- Phase 310 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Hoffmann-La Roche2 trials
- ALX Oncology Inc.1 trial
- Bristol-Myers Squibb1 trial
- Gilead Sciences1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Lung cancer2 recruiting
- Multiple myeloma2 recruiting
- Ovarian cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026